Everything below concerns REV-ERB agonist. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-02-10. Where a claim depends on a specific study, the study is described rather than over-claimed.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| Molecular weight | 437.9 g/mol | Calculated from the formula |
| Primary target | REV-ERBα and REV-ERBβ | Nuclear receptors involved in circadian regulation |
| Solubility | Soluble in DMSO and ethanol | Poorly soluble in water |
| Typical storage | -20 °C, desiccated | Protect from light and moisture |
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
Reynolds was powerless to prevent the inevitable; although leading at half-time, Geelong kicked five goals to Essendon's two points in the third quarter to set up victory by 11 points. Essendon slumped to 8th in 1952, but Coleman was in strong form, managing 103 goals for the year. Two seasons later, Coleman's career was ended after he dislocated a knee during the Round 8 clash with the North Melbourne Football Club at Essendon. Aged just 25, he had kicked 537 goals in only 98 VFL games. Following Coleman's career-ending knee injury, Essendon won no further premierships in the 1950s. In 1957, Essendon defeated Melbourne by 16 points in the Second Semi-Final, but lost the grand final to Melbourne by 61 points. The 1959 season ended with a 37-point grand final loss to Melbourne. Essendon would win their next premiership three years later in 1962.
"Lidocaine Transdermal Patch". MedlinePlus. US patent 2441498, Nils Magnus Loefgren & Bengt Josef Lundqvist, "Alkyl glycinanilides", published 11 May 1948, issued 11 May 1948, assigned to ASTRA APOTEKARNES KEM FAB
Upper Crust is an international chain of baguette restaurants concentrated along commuter routes. The outlets are commonplace in stations and terminals. There are branches at the central railway station in Oslo and Elkjøp Megastore Lørenskog, Norway. Since September 2008, there are also three units in Stockholm, Sweden – two at the central railway station and one at the nearby bus terminal, Cityterminalen. There is also one in the Gothenburg Central Station, and one in Euston Station, London. The company has started to expand into shopping centres, with a new store at Bridgend Designer Outlet, South Wales. There are also branches in airports, including Cairo Airport, Tromsø Airport, Trondheim Værnes Airport, Oslo Airport Gardermoen, Helsinki Airport, Toronto Airport, Sofia Vasil Levski Airport, George Bush Intercontinental Airport and Gran Canaria Airport. They were located in Australia too in the past, at places such as Circular Quay.
By preventing black from the ability to attain mortgage loans from local banks, the New Deal private-public partnerships used redlining to protect the property values and investment opportunities for white middle-class homes. Therefore, redlining circumscribed black homeownership in middle-class neighborhoods through the spatial and social isolation of black Detroiters in Detroit's expanding ghettos. Simultaneously, this residential segregation also exacerbated the economic instability of black Detroiters as these residents were forced to succumb to deteriorating housing without appreciating assets while the high rates of unemployment of black Detroiters made them exceedingly vulnerable to losing their homes through eviction or tax foreclosure. Because the local government had the final say over the distribution of federal funds for home loan eligibility, there were no major alternatives for obtaining loans for a new home, which further promoted the precarious and unstable living conditions of black Detroiters. The redemptive capacity of the private-public partnership between local Detroit banks and the FHA-HOLC funneled a vicious territorialism of the white middle class that upheld the high property values of white neighborhoods by unequivocally suppressing the upward mobility of black Detroiters. Collectively, black integration into white neighborhoods greatly depreciated property values, further motivating white Detroiters to keep their neighborhoods segregated.
=== Viscosity === Semen viscosity can be estimated by gently aspirating the sample into a wide-bore plastic disposable pipette, allowing the semen to drop by gravity and observing the length of any thread. High viscosity can interfere with determination of sperm motility, sperm concentration and other analysis.
Sources: en.wikipedia.org
=== Structure === The dihydroxyquinoline core is composed of (1S)-5-amino-2,3-dihydro- 8,9-dihydroxy-1H-pyrimido[1,2-a]quinoline-1-carboxylic acid. This portion of the molecule is invariant amongst all observed pyoverdine molecules. The core is modified by the addition of an amino acid chain composed of 6-14 amino acids. The chain of amino acids is built onto the chromophore core, and is synthesized via non-ribosomal peptide synthesis. As is common for non-ribsosomally synthesized peptides, pyoverdine frequently includes D-form amino acids and non-standard amino acids, such as N-5-formyl-N-5-hydroxyornithine. The peptide chain may also be partially (or completely) cyclized. This peptide chain provides the other four aspects of the hexadentate interaction, usually through hydroxamate and/or hydroxycarboxylate groups. This portion of the molecule is also crucial for interaction with the ferripyoverdine receptor (FpvA) that allows ferripyoverdine to be imported into the cell. The peptide chain produced by a given strain of Pseudomonas is currently thought to be invariant. Little is known about the particular function or importance of the ketoacid side chain, but it is well known that pyoverdine molecules with different ketoacids (congeners) co-exist. Ketoacids that have been observed include succinate/succinamide, glutamate, glutarate, malate/malamide, and α-ketoglutarate.
=== Endothelial dysfunction and diabetic would healing === ITGA1 has been associated with vascular dysfunction in diabetic would healing, more specifically diabetic foot ulcers. Increased ITGA1 expression has been observed in diabetic wound tissues and AGEs-treated human umbilical vein endothelial cells (HUVECs). While elevated ITGA1 expression contributes to endothelial cell dysfunction by impairing proliferation, migration, and tube formation, while promoting cellular senescence; inhibiting ITGA1 restores endothelial cell function. This suggests ITGA1's contribution to diabetic wound pathology, and may represent a potential therapeutic target for vascular repair.
==== Elimination ==== Atomoxetine and its metabolites are eliminated mainly via excretion into urine. Less than 3% of atomoxetine is excreted unchanged in urine regardless of CYP2D6 status, indicating extensive metabolism. In CYP2D6 extensive metabolizers, who are considered to have normal CYP2D6 activity, more than 96% of a dose of radiolabeled atomoxetine is excreted in urine within 24 hours and 1 to 2% is excreted in feces. Conversely, in CYP2D6 poor metabolizers, excretion is slower, with only 27% excreted after 24 hours, a majority of radioactivity excreted within 72 hours, and ~144 hours required for full excretion. In addition, only 80% of radioactivity is excreted in urine while 13 to 22% is excreted in feces in CYP2D6 poor metabolizers. The major excreted metabolite of atomoxetine is 4-hydroxyatomoxetine glucuronide, which accounts for >80% of the dose in urine but <17% of the dose in feces. The fractions excreted in urine as 4-hydroxyatomoxetine and 4-hydroxyatomoxetine glucuronide account for 86% of a dose in CYP2D6 extensive metabolizers, but only 40% in CYP2D6 poor metabolizers. CYP2D6 poor metabolizers excrete greater amounts of minor atomoxetine metabolites, namely N-desmethylatomoxetine and 2-hydroxymethylatomoxetine and their conjugates, than extensive metabolizers. The elimination half-life of atomoxetine is 4.5 to 5.3 hours in CYP2D6 extensive metabolizers. However, in CYP2D6 poor metabolizers, the half-life of atomoxetine is 19 to 21.6 hours, or about 4-fold longer in comparison.
Since the 1962–1965 rubella epidemic that swept Europe in 1962-1963 and the US in 1964–1965, several efforts were made to develop effective vaccines using attenuated viral strains, both in US and abroad.
=== Collaboration and faster advancements === Large-scale collaborations, such as those seen in the development of open-source frameworks like TensorFlow and PyTorch, have accelerated advancements in machine learning (ML) and deep learning. The open-source nature of these platforms also facilitates rapid iteration and improvement, as contributors from across the globe can propose modifications and enhancements to existing tools.
Sources: en.wikipedia.org
It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.
It binds to REV-ERBα and REV-ERBβ, nuclear receptors involved in circadian and metabolic gene regulation. This can alter transcription of genes related to lipid and glucose metabolism in experimental models.
No controlled human trials have established that effect. Endurance findings come primarily from rodent studies, and human responses remain unknown.
Its legal status depends on the country and intended use. It is not an approved medicine in major jurisdictions. In sport, it is prohibited by anti-doping rules.